Our model outperformed other models with a C-index of approximately 83% and 70% and an accuracy of 85% and 83%, when classifying patient survival (short or long survival) using CD276 dataset and the TCGA GBM dataset, respectively. This evidence concerns the gene CD276 and glioblastoma.